Cargando…

Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters

BACKGROUND: Immunotherapy has transformed cancer treatment patterns for advanced hepatocellular carcinoma (aHCC) in recent years. Therefore, the identification of predictive biomarkers has important clinical implications. METHODS: We collected medical records from 117 aHCC patients treated with anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Guhe, Qiu, Lupeng, Zheng, Hongye, Qin, Boyu, Sun, Zhuoya, Shao, Yangyang, Yang, Zizhong, Shao, Jiakang, Zhou, Yuxin, Jiao, Shunchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273750/ https://www.ncbi.nlm.nih.gov/pubmed/37328805 http://dx.doi.org/10.1186/s12885-023-11064-1

Ejemplares similares

Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis
por: Qiu, Lupeng, et al.
Publicado: (2022)

Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis
por: Yang, Zizhong, et al.
Publicado: (2021)

Relationship Between MUC4 Variants and Metastatic Recurrence in Colorectal Cancer
por: Liu, Jieqiong, et al.
Publicado: (2023)

Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
por: Qiu, Lupeng, et al.
Publicado: (2020)

A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters
por: Chang, Yau-Ren, et al.
Publicado: (2021)

A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Wang, Mengmeng, et al.
Publicado: (2018)

Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study
por: Lu, Zhenhua, et al.
Publicado: (2021)

MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma
por: Wang, Yuxin, et al.
Publicado: (2023)

Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment
por: Liu, Yao, et al.
Publicado: (2020)

Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response
por: Jiang, Hongye, et al.
Publicado: (2021)

Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection
por: Liao, Rui, et al.
Publicado: (2022)

Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma
por: Zhu, Yuandong, et al.
Publicado: (2019)

Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
por: Wan, Gang, et al.
Publicado: (2017)

15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma
por: Zhang, Qiong, et al.
Publicado: (2020)

Pre-treatment EEG signal variability is associated with treatment success in depression
por: Jaworska, Natalia, et al.
Publicado: (2017)

Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study
por: Chen, San-Chi, et al.
Publicado: (2022)

Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario
por: Leong, Joon Yau, et al.
Publicado: (2019)

The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With Chemotherapy
por: Wu, Liangliang, et al.
Publicado: (2021)

Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma
por: Zhang, Lu-Lu, et al.
Publicado: (2020)

The pre- and postoperative nomograms to predict the textbook outcomes of patients who underwent hepatectomy for hepatocellular carcinoma
por: Xie, Gui-Lin, et al.
Publicado: (2023)

Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma
por: Zhang, Ze, et al.
Publicado: (2023)

Intra-articular Injection of Kartogenin-Incorporated Thermogel Enhancing Osteoarthritis Treatment
por: Wang, Shao-Jie, et al.
Publicado: (2019)

Prognostic nomogram incorporating radiological features for predicting overall survival in patients with AIDS-related non-Hodgkin lymphoma
por: Li, Xueqin, et al.
Publicado: (2022)

Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer
por: Ren, Dong-Lin, et al.
Publicado: (2019)

Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma
por: Yang, Chengkai, et al.
Publicado: (2023)

A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer
por: Wang, Lingxiong, et al.
Publicado: (2021)

Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer
por: Wang, Xueping, et al.
Publicado: (2023)

A Nomogram Incorporating Neutrophil-to-Lymphocyte Ratio and Squamous Cell Carcinoma Antigen Predicts the Prognosis of Oral Cancers
por: Tsai, Yao-Te, et al.
Publicado: (2023)

Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab
por: Wang, Yu, et al.
Publicado: (2021)

Enhancing anti-tumor efficacy and immune memory by combining 3p-GPC-3 siRNA treatment with PD-1 blockade in hepatocellular carcinoma
por: Shao, Liwei, et al.
Publicado: (2022)

A nomogram incorporating Ki67 to predict survival of acral melanoma
por: Du, Yu, et al.
Publicado: (2023)

Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma
por: Li, Ning, et al.
Publicado: (2022)

A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
por: Duan, Jingjing, et al.
Publicado: (2018)

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)
por: Han, Chun, et al.
Publicado: (2021)

Nomogram for Estimating the Risks of Intestinal Ischemia and Necrosis in Neonates With Midgut Volvulus: A Retrospective Study
por: Guan, Xisi, et al.
Publicado: (2022)

Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma
por: Hu, Hao, et al.
Publicado: (2016)

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma
por: Hsu, Chia-Yang, et al.
Publicado: (2017)

Persuasion with Limited Sight
por: Lascarides, Alex, et al.
Publicado: (2018)

Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2022)

Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma
por: Lim, Mir, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aiqn0lkpdh0t5l92n79ejk816m